NCK a much better pick for the cyclical investment thesis even at its current valuation. You pay for the quality and enjoy a much stronger ride on the up cycle. IMO
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025